Table 3.
Methodological Differences in Relation to Cardiac Structure and Function
| 3A. Teichholz | |||
| Δ Stroke Volume vs. CMR | |||
| Present | Absent | P | |
| LV Chamber Remodeling* | |||
| LV Dilation | 2 ± 17 ml | −0.4 ± 13 ml | 0.54 |
| LV Segmental (≥ Moderate) Hypokinesis | |||
| Anterior | −3 ± 15 ml | 1 ± 13 ml | 0.12 |
| Anteroseptal | −3 ± 12 ml | 2 ± 15 ml | 0.01 |
| Inferoseptal | −3 ± 14 ml | 1 ± 13 ml | 0.08 |
| Inferior | −0.1 ± 15 ml | −0.2 ± 13 ml | 0.99 |
| Inferolateral | −5 ± 15 ml | 0.9 ± 13 ml | 0.049 |
| Anterolateral | −9 ± 11 ml | 0.7 ± 14 ml | 0.015 |
| Aortic Abnormalities‡ | |||
| 3 ± 15 ml | −1 ± 14 ml | 0.30 | |
| 3B. Doppler | |||
| Δ Stroke Volume vs. CMR (ml) | |||
| Present | Absent | P | |
| LV Chamber Remodeling* | |||
| LV Dilation | −1 ± 17 ml | −3 ± 14 ml | 0.61 |
| LV Segmental (≥ Moderate) Hypokinesis | |||
| Anterior | −2 ± 14 ml | −3 ± 14 ml | 0.57 |
| Anteroseptal | −3 ± 14 ml | −3 ± 15 ml | 0.91 |
| Inferoseptal | −3 ± 14 ml | −3 ± 15 ml | 0.84 |
| Inferior | −3 ± 14 ml | −3 ± 14 ml | 0.95 |
| Inferolateral | −3 ± 15 ml | −3 ± 14 ml | 0.98 |
| Anterolateral | −3 ± 17 ml | −3 ± 14 ml | 0.98 |
| Aortic Abnormalities‡ | |||
| 4 ± 16 ml | −4 ± 14 ml | 0.02 | |
Threshold based on 1 standard deviation above mean (LVEDD ≥ 6.4cm)
Aortic root dilation (>4cm), or bicuspid/stenotic/sclerotic aortic valve